PMID- 25673840 OWN - NLM STAT- MEDLINE DCOM- 20150413 LR - 20200225 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 35 IP - 6 DP - 2015 Feb 11 TI - Secreted ectodomain of sialic acid-binding Ig-like lectin-9 and monocyte chemoattractant protein-1 promote recovery after rat spinal cord injury by altering macrophage polarity. PG - 2452-64 LID - 10.1523/JNEUROSCI.4088-14.2015 [doi] AB - Engrafted mesenchymal stem cells from human deciduous dental pulp (SHEDs) support recovery from neural insults via paracrine mechanisms that are poorly understood. Here we show that the conditioned serum-free medium (CM) from SHEDs, administered intrathecally into rat injured spinal cord during the acute postinjury period, caused remarkable functional recovery. The ability of SHED-CM to induce recovery was associated with an immunoregulatory activity that induced anti-inflammatory M2-like macrophages. Secretome analysis of the SHED-CM revealed a previously unrecognized set of inducers for anti-inflammatory M2-like macrophages: monocyte chemoattractant protein-1 (MCP-1) and the secreted ectodomain of sialic acid-binding Ig-like lectin-9 (ED-Siglec-9). Depleting MCP-1 and ED-Siglec-9 from the SHED-CM prominently reduced its ability to induce M2-like macrophages and to promote functional recovery after spinal cord injury (SCI). The combination of MCP-1 and ED-Siglec-9 synergistically promoted the M2-like differentiation of bone marrow-derived macrophages in vitro, and this effect was abolished by a selective antagonist for CC chemokine receptor 2 (CCR2) or by the genetic knock-out of CCR2. Furthermore, MCP-1 and ED-Siglec-9 administration into the injured spinal cord induced M2-like macrophages and led to a marked recovery of hindlimb locomotor function after SCI. The inhibition of this M2 induction through the inactivation of CCR2 function abolished the therapeutic effects of both SHED-CM and MCP-1/ED-Siglec-9. Macrophages activated by MCP-1 and ED-Siglec-9 extended neurite and suppressed apoptosis of primary cerebellar granule neurons against the neurotoxic effects of chondroitin sulfate proteoglycans. Our data suggest that the unique combination of MCP-1 and ED-Siglec-9 repairs the SCI through anti-inflammatory M2-like macrophage induction. CI - Copyright (c) 2015 the authors 0270-6474/15/352452-13$15.00/0. FAU - Matsubara, Kohki AU - Matsubara K AD - Department of Oral and Maxillofacial Surgery. FAU - Matsushita, Yoshihiro AU - Matsushita Y AUID- ORCID: 0000-0001-7447-061X AD - Department of Oral and Maxillofacial Surgery. FAU - Sakai, Kiyoshi AU - Sakai K AD - Department of Oral and Maxillofacial Surgery. FAU - Kano, Fumiya AU - Kano F AD - Department of Oral and Maxillofacial Surgery. FAU - Kondo, Megumi AU - Kondo M AD - Department of Oral and Maxillofacial Surgery. FAU - Noda, Mariko AU - Noda M AUID- ORCID: 0000-0002-6066-1359 AD - Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Chikusa-ku, Nagoya 464-8601, Japan. FAU - Hashimoto, Noboru AU - Hashimoto N AD - Biochemistry II, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan, and. FAU - Imagama, Shiro AU - Imagama S AD - Orthopedic Surgery, and. FAU - Ishiguro, Naoki AU - Ishiguro N AD - Orthopedic Surgery, and. FAU - Suzumura, Akio AU - Suzumura A AD - Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Chikusa-ku, Nagoya 464-8601, Japan. FAU - Ueda, Minoru AU - Ueda M AD - Department of Oral and Maxillofacial Surgery. FAU - Furukawa, Koichi AU - Furukawa K AD - Biochemistry II, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan, and. FAU - Yamamoto, Akihito AU - Yamamoto A AD - Department of Oral and Maxillofacial Surgery, akihito@med.nagoya-u.ac.jp. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Antigens, CD) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Culture Media, Conditioned) RN - 0 (Cytokines) RN - 0 (Receptors, CCR2) RN - 0 (SIGLEC9 protein, human) RN - 0 (Sialic Acid Binding Immunoglobulin-like Lectins) SB - IM MH - Animals MH - Antigens, CD/metabolism/*pharmacology MH - Blood-Brain Barrier/drug effects MH - Brain Injuries/drug therapy MH - Cell Polarity/drug effects MH - Cerebellum/cytology/drug effects/metabolism MH - Chemokine CCL2/metabolism/*pharmacology MH - Child MH - Culture Media, Conditioned MH - Cytokines/metabolism MH - Dental Pulp/cytology/metabolism MH - Humans MH - Macrophages/*drug effects MH - Mice MH - Mice, Inbred C57BL MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, CCR2/antagonists & inhibitors MH - Sialic Acid Binding Immunoglobulin-like Lectins/metabolism/*pharmacology MH - Spinal Cord Injuries/*drug therapy/pathology MH - Tooth, Deciduous PMC - PMC6605605 OTO - NOTNLM OT - MCP-1 OT - Siglec-9 OT - anti-inflammation OT - dental pulp stem cells OT - macrophage polarity OT - spinal cord injury EDAT- 2015/02/13 06:00 MHDA- 2015/04/14 06:00 PMCR- 2015/08/11 CRDT- 2015/02/13 06:00 PHST- 2015/02/13 06:00 [entrez] PHST- 2015/02/13 06:00 [pubmed] PHST- 2015/04/14 06:00 [medline] PHST- 2015/08/11 00:00 [pmc-release] AID - 35/6/2452 [pii] AID - 4088-14 [pii] AID - 10.1523/JNEUROSCI.4088-14.2015 [doi] PST - ppublish SO - J Neurosci. 2015 Feb 11;35(6):2452-64. doi: 10.1523/JNEUROSCI.4088-14.2015.